GLP‑1 drugs like Ozempic show promise for more than weight loss, but what's science vs. hype?
You've probably heard of Ozempic or Wegovy. These are the injectable drugs that have become household names for weight loss and diabetes.
23 hours ago
0
2
Urogenital Diseases: News and Research on Genital Diseases, Female
MeSH tree: C12.050.351.500
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer
Previously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab in combination with chemotherapy improved overall survival for patients ...
Jun 1, 2026
0
4
Renaming PCOS to PMOS—a 10‑year process of listening to patients and health professionals
A disease's name can have a significant influence on its diagnosis and treatment—or lack thereof. Polycystic ovary syndrome, or PCOS, is a condition that affects millions of people worldwide. For decades, doctors thought ...
Jun 1, 2026
0
3
Not just ovaries—new name for PCOS reflects the condition's multisystem nature
An estimated 1 in 8 women live with polycystic ovarian syndrome, commonly referred to as PCOS. However, the name is a bit of a misnomer; it suggests that the condition affects only the ovaries. In actuality, the condition ...
May 29, 2026
0
7
Pain during intercourse is still not widely discussed
Pain during intercourse is a topic that still rarely breaks into the public debate on health. As shown in the latest analysis published in the Journal of Clinical Medicine, dyspareunia affects up to one in five women. It ...
May 28, 2026
0
3
Oral inflammation may reach ovaries, speeding fertility decline, mouse study suggests
A new study led by Prof. Michael Klutstein at the Hebrew University of Jerusalem and Prof. Asaf Wilensky at the Hebrew University-Hadassah Medical Center and spearheaded by the students Dr. Paz Kles and Stephen Ameho has ...
May 28, 2026
0
4
Report shows polyendocrine metabolic ovarian syndrome needs more than just a name change
Earlier this month, endocrinology specialists at the European Congress of Endocrinology announced that Polycystic Ovary Syndrome (PCOS) is being renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better reflect the ...
May 26, 2026
0
4
Breast cancer drug is effective for treatment-resistant uterine cancer
Uterine cancer is the deadliest cancer of the female reproductive system. Currently, clinicians treat the disease by using a mix of surgery and chemotherapy. But not everyone responds to this line of treatment, and those ...
May 21, 2026
0
5
HPV self-collection boosts screening completion and cuts pelvic exams by one-third
A Kaiser Permanente study published by NEJM Catalyst Innovations in Care Delivery provides real-world data on a new approach to cervical cancer screening: giving patients the option to skip the traditional pelvic exam and ...
May 20, 2026
0
5
Sexual problems common after cancer in young adults
Each year, approximately 2,000 people aged 18–39 are diagnosed with cancer in Sweden. Most survive their illness, but for many, life continues with long-term consequences. In a new doctoral dissertation, Charlotta Bergström ...
May 19, 2026
0
3
